Sleep Apnoea E017
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/q-z/sleep-apnoea-e017-g4730g4731g4732g
Factors in CCPS as at 18 July 2005 (E017)
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/alphabetic-index-statements-principles/q-z/sleep-apnoea-e017/factors-ccps-18-july-2005-e017
Acromegaly
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/acromegaly
Alcohol consumption
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/alcohol-consumption
Autonomic neuropathy
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/autonomic-neuropathy
Being obese
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/being-obese
Chronic obstruction of the upper airways
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/chronic-obstruction-upper-airways
Congestive cardiac failure
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/congestive-cardiac-failure
Disorder of cervical cord or brain stem or cerebrum or extrapyramidal system
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/disorder-cervical-cord-or-brain-stem-or-cerebrum-or-extrapyramidal-system
End stage renal failure
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/end-stage-renal-failure
Hypothyroidism
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/hypothyroidism
Inability to obtain appropriate clinical management for sleep apnoea
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/inability-obtain-appropriate-clinical-management-sleep-apnoea
Infection with the human immunodeficiency virus (HIV)
Current RMA Instruments
| Reasonable Hypothesis SOP | 68 of 2022 |
| Balance of Probabilities SOP | 69 of 2022 |
Changes from previous Instruments
ICD Coding
- ICD-10-AM Codes: G47.30, G47.31, G47.32, G47.39
Brief description
This is a sleep disorder characterised by periods of cessation or reduction in airflow in the upper airway, leading to recurrent episodes of arousals and disrupted sleep. This condition can result in excessive daytime sleepiness, impaired memory, difficulty concentrating, morning headaches, high blood pressure, and other cardiac and respiratory complications.
There are three types of sleep apnoea:
- Central sleep apnoea, where there is repetitive cessation or decrease of both airflow and respiratory effort during sleep (due to diminished or absent central respiratory drive)
- Obstructive sleep apnoea, where there is repetitive cessation or decrease of airflow during sleep despite respiratory effort
- Mixed sleep apnoea where central sleep apnoea is followed by an obstructive component
Confirming the diagnosis
This diagnosis will generally require an opinion from a Sleep/Respiratory Physician and will be based on clincial assessment and appropriate investigations, including a sleep study. The type of sleep apnoea needs to be known to apply a number of the SOP factors.
Additional diagnoses covered by SOP
- Central sleep apnoea
- Mixed sleep apnoea
- Obstructive sleep apnoea
- Upper airway resistance syndrome (a variant of obstructive sleep apnoea)
Conditions excluded from SOP
- Narcolepsy*
- Sleep manifestations of a psychiatric disorder
- Insufficient sleep
- Idiopathic hypersomnia#
- Chronic Insomnia Disorder*
- Sleep-related hypoventilation disorders#
* another SOP applies- the SOP has the same name unless otherwise specified
# non-SOP condition
Clinical onset
Clinical onset will generally coincide with confirmation of the diagnosis by a sleep/respiratory physician. This is a threshold diagnosis, based on the number of hypopnoea/apnoea episodes per hour of sleep, so backdating of onset to before a sleep study will generally be difficult.
Clinical worsening
Clinical worsening may be evidenced by an increase in the number or duration of apnoea or hypopnoea episodes or in the severity of associated clinical consequences. The development of related health consequences such as cardiovascular diseases does not represent a worsening of the sleep apnoea per se. The condition is amenable and responsive to treatment, including lifestyle measures (e.g. weight loss) and continuous positive airway pressure therapy.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/sleep-apnoea-e017-g4730g4731g4732g/rulebase-sleep-apnoea/infection-human-immunodeficiency-virus-hiv